- Home
- GROY vs MLAB Comparison
GROY vs MLAB Comparison
Compare GROY & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GROY | MLAB |
|---|---|---|
| Founded | 2020 | 1982 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.6M | 533.0M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GROY | MLAB |
|---|---|---|
| Price | $2.61 | $101.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $5.90 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 1.8M | 146.3K |
| Earning Date | 05-06-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | N/A |
| Revenue This Year | $145.80 | $6.07 |
| Revenue Next Year | $60.03 | $5.41 |
| P/E Ratio | ★ N/A | $83.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.45 | $59.63 |
| 52 Week High | $5.45 | $113.99 |
Technical Indicators
Market Signals| Indicator | GROY | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 45.72 | 50.50 |
| Support Level | $2.45 | $94.01 |
| Resistance Level | $2.72 | $106.49 |
| Average True Range (ATR) | 0.09 | 4.15 |
| MACD | 0.03 | 0.47 |
| Stochastic Oscillator | 64.15 | 67.19 |
Price Performance
Historical ComparisonAbout GROY Gold Royalty Corp.
Gold Royalty Corp is principally engaged in acquiring gold-focused royalties, streaming, and similar interests. It is a gold-focused royalty company offering creative financing solutions to the metals and mining industry. The Company operates in Bosnia and Herzegovina, Canada, which generates maximum revenue, the USA, Brazil, and Mexico.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.